drugset / Trial / NCT02949895
Study of BMS-986012 in Subjects With Small Cell Lung Caner
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A study to evaluate safety and tolerability of BMS-986012 in patients with small cell lung cancer
Timeline
- Start
- 2016-11-29
- Primary completion
- 2017-08-29
- Completion
- 2017-08-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | atigotatug | Monoclonal antibody | — | — |
| Background | Cisplatin | Other / unclassified | — | — |
| Background | Etoposide | Small molecule | — | — |